A new report from the Organization for Economic Cooperation and Development (OECD), an intergovernmental body whose membership comprises a group of 36 mostly developed countries, describes […]
In a startling development, multinational pharma company Bayer has publicly admitted that biotech company Monsanto, which it purchased for $63 billion in 2018, had been keeping […]
In yet another damaging development for the pharma industry’s multi-billion-dollar statins business, a large study has revealed that, in more than 51 percent of patients, the […]
On Thursday 4 April 2019, our Foundation published an article describing how, due to the growing problems following Bayer’s takeover of Monsanto, the company’s situation could […]
The Monsanto takeover in 2018 promised big business for Bayer. At a time of intense pressure on pharmaceutical companies, the strengthening of Bayer’s agrichemical division seemed […]